HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

l-methyl-2-pyridone-5-carboxamide

niacin metabolite

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - Pyridones: 14
      - l-methyl-2-pyridone-5-carboxamide: 1

Experts

1.	Auld, Andrew F: 1 article (01/2020)
2.	Buono, Nicole: 1 article (01/2020)
3.	Chisuwo, Laphiod: 1 article (01/2020)
4.	Chiwaula, Mabvuto J: 1 article (01/2020)
5.	Girma, Belaineh: 1 article (01/2020)
6.	Gregory, Jesse F: 1 article (01/2020)
7.	Gunde, Laurence J: 1 article (01/2020)
8.	Gutreuter, Steve: 1 article (01/2020)
9.	Jahn, Andreas: 1 article (01/2020)
10.	Kalua, Thokozani: 1 article (01/2020)

Related Diseases

1.

01/01/2020 - "Secondary aims include measuring time from isoniazid initiation to onset of dermatitis, comparing niacin metabolites 1-methylnicotinamide (1-MN), and l-methyl-2-pyridone-5-carboxamide (2-PYR) in urine as a proxy for total body niacin status among subpopulations, and describing clinical outcomes after 30-days multi-B vitamin (containing 300 mg nicotinamide daily) therapy and isoniazid cessation (if exposed). "

Related Drugs and Biologics

1.	Vitamin B Complex (B Vitamins)
2.	Niacinamide (Nicotinamide)
3.	Niacin (Nicotinic Acid)
4.	Isoniazid (Ftivazide)
5.	N(1)-methylnicotinamide

Related Therapies and Procedures

1.	Therapeutics